Masimo Corp. (MASI)
142.05
+2.18
(+1.56%)
USD |
NASDAQ |
Jan 16, 16:00
142.12
+0.07
(+0.05%)
After-Hours: 20:00
Masimo EPS Diluted (Quarterly): -1.859 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| West Pharmaceutical Services, Inc. | 1.928 |
| Insulet Corp. | 1.240 |
| ResMed, Inc. | 2.373 |
| UFP Technologies, Inc. | 2.106 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 53.70M |
| Revenue (Quarterly) | 371.50M |
| Total Expenses (Quarterly) | 317.80M |
| Enterprise Value | 7.902B |
| Gross Profit Margin (Quarterly) | 62.07% |
| Profit Margin (Quarterly) | 14.45% |
| Earnings Yield | -7.47% |
| Operating Earnings Yield | 2.26% |
| Normalized Earnings Yield | -4.632 |